New Nature Study Shows CapScan® Provides Novel Insights into the Human Gut Microbiome and Metabolome
10 May 2023, San Francisco CA – Envivo Bio, a biotech company advancing the gut microbiome and metabolome field, announced
New Nature Metabolism Study Demonstrates CapScan® Uniquely Profiles Dietary and Lipid Compounds in the Gut Metabolome
10 May 2023, San Francisco CA – Envivo Bio, a biotech company advancing the gut microbiome and metabolome field, announced
National Science Foundation Awards Envivo Bio a Phase 1 SBIR Grant
22 January 2020, San Carlos CA – The National Science Foundation (NSF) has awarded a Phase 1 Small Business Innovation
Envivo Bio Awarded NSF SBIR Phase 2 Grant for Innovative Technology Development
10 September 2021, San Carlos CA – Envivo Bio has been awarded a National Science Foundation (NSF) Small Business Innovation
NIH Awards Grant for Development and Clinical Evaluation of the CapScan® Device
24 March 2022, San Carlos CA – Envivo Bio has been awarded a grant from the National Cancer Institute (NCI)
Envivo Bio to Study Environmental Enteropathy Using its CapScan® Intestinal Sampling Device
22 May 2022, San Carlos, CA – Envivo Bio will participate in an environmental enteropathy study, led by researchers from
Envivo Bio Awarded NSF SBIR TECP Grant for Innovative Medical Device
9 December 2022, San Carlos CA – Envivo Bio, a leader in gut microbiome